Cibc Asset Management Inc Novartis Ag Transaction History

Cibc Asset Management Inc

$28 Billion
Q4 2024

A detailed history of Cibc Asset Management Inc transactions in Novartis Ag stock. As of the latest transaction made, Cibc Asset Management Inc holds 19,109 shares of NVS stock, worth $2.14 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

19,109

Previous 19,089 0.1%

Holding current value

$2.14 Million

Previous $2.2 Million 15.31%

% of portfolio

0.01%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 31, 2025	BUY	$96.78 - $117.18 $1,935 - $2,343	20 Added 0.1%	19,109 $1.86 Million
Q3 2024 Nov 06, 2024	SELL	$106.13 - $120.89 $551,239 - $627,902	-5,194 Reduced 21.39%	19,089 $2.2 Million
Q2 2024 Aug 01, 2024	BUY	$92.57 - $107.37 $2.25 Million - $2.61 Million	24,283 New	24,283 $2.59 Million
Q2 2022 Aug 09, 2022	SELL	$80.52 - $93.75 $459,849 - $535,406	-5,711 Closed	0 $0
Q1 2022 May 06, 2022	BUY	$80.11 - $90.62 $457,508 - $517,530	5,711 New	5,711 $501,000
Q2 2021 Aug 16, 2021	SELL	$85.24 - $94.15 $247,707 - $273,599	-2,906 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$83.5 - $98.47 $2.23 Million - $2.63 Million	-26,687 Reduced 90.18%	2,906 $249,000
Q4 2020 Feb 03, 2021	BUY	$78.07 - $94.43 $303,301 - $366,860	3,885 Added 15.11%	29,593 $2.79 Million
Q3 2020 Nov 05, 2020	SELL	$82.14 - $91.0 $163,869 - $181,545	-1,995 Reduced 7.2%	25,708 $2.24 Million
Q2 2020 Jul 28, 2020	SELL	$80.93 - $91.1 $1.23 Million - $1.39 Million	-15,215 Reduced 35.45%	27,703 $2.42 Million
Q1 2020 Apr 30, 2020	SELL	$70.67 - $99.01 $18,374 - $25,742	-260 Reduced 0.6%	42,918 $3.54 Million
Q4 2019 Feb 14, 2020	SELL	$84.35 - $95.37 $20,581 - $23,270	-244 Reduced 0.56%	43,178 $4.09 Million
Q3 2019 Oct 30, 2019	SELL	$85.54 - $94.26 $411,105 - $453,013	-4,806 Reduced 9.97%	43,422 $3.77 Million
Q2 2019 Aug 05, 2019	SELL	$75.4 - $92.8 $1.54 Million - $1.89 Million	-20,419 Reduced 29.74%	48,228 $4.4 Million
Q1 2019 May 06, 2019	BUY	$75.32 - $86.15 $1.03 Million - $1.18 Million	13,650 Added 24.82%	68,647 $6.6 Million
Q4 2018 Feb 12, 2019	SELL	$73.66 - $82.02 $30,937 - $34,448	-420 Reduced 0.76%	54,997 $4.72 Million
Q3 2018 Nov 02, 2018	SELL	$66.94 - $77.43 $95,054 - $109,950	-1,420 Reduced 2.5%	55,417 $4.78 Million
Q2 2018 Aug 09, 2018	SELL	$64.91 - $73.36 $118,785 - $134,248	-1,830 Reduced 3.12%	56,837 $4.29 Million
Q1 2018 Apr 30, 2018	SELL	$70.39 - $84.15 $78,836 - $94,248	-1,120 Reduced 1.87%	58,667 $4.74 Million
Q4 2017 Feb 02, 2018	BUY	$72.33 - $77.64 $22,566 - $24,223	312 Added 0.52%	59,787 $5.02 Million
Q3 2017 Nov 06, 2017	BUY	$74.14 - $77.27 $4.41 Million - $4.6 Million	59,475	59,475 $5.11 Million

Others Institutions Holding NVS

# of Institutions

1,477

Shares Held

134M

Call Options Held

1.31M

Put Options Held

1.56M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $241B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Asset Management Inc with notifications on news.

Account

Cibc Asset Management Inc Novartis Ag Transaction History